Gapping upIn reaction to strong earnings/guidance:
- GES +12.2%, CSPR +11.4%, POL +6.9% (reaffirms guidance), DOYU +6.1%, MOMO +6%, MLHR +5.6%, TCOM +4.5%, WSM +3.7%, ACN +2.6%, CMC +1%, CMC +1%, FIVE +0.8%
Select ETFs showing strength:
- XLC +2.9%, XLE +1%, XLB +0.9%, GDX +0.9%
Other news:
- CHEF +20% (issues update on liquidity)
- BTAI +19.5% (announced that more than one-third of the patients in the Phase 3 SERENITY trials have been enrolled and treated)
- CODX +11.7% (JV receives license in India to sell COVID-19 test kits)
- AEG +8.1% (provides update on capital position; Aegon remains well capitalized in the upper half of the Solvency II ratio target range)
- KL +2.8% (increases dividend)
- ICE +1.9% (to move temporarily to fully electronic trading, effective March 23)
- ABT +1.3% (announces that the FDA has issued Emergency Use Authorization (EUA) for the co's molecular test for novel coronavirus)
- CBTX +1% (suspends share repurchase program)
Analyst comments:
- APHA +2.8% (upgraded to Buy from Neutral at BofA/Merrill)
- DPZ +1% (upgraded to Hold from Sell at Deutsche Bank)
